{
    "2019-12-18": [
        [
            {
                "time": "2023-10-01",
                "original_text": "AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for the Combination VENCLEXTA® With Rituximab as a Treatment for Patients With Chronic Lymphocytic Leukemia (CLL)",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "agreement",
                        "pCPA",
                        "VENCLEXTA",
                        "Rituximab",
                        "CLL"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AbbVie Receives European Commission Approval of RINVOQ™ (upadacitinib) for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "European Commission",
                        "RINVOQ",
                        "Approval",
                        "Rheumatoid Arthritis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AbbVie’s Humira Sales in Europe Appear to Be Holding Up Better Than Anticipated",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Humira",
                        "Sales",
                        "Europe"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "ImmunoGen Lead Drug Gets Nod for Accelerated Approval Pathway",
                "features": {
                    "keywords": [
                        "ImmunoGen",
                        "Lead Drug",
                        "Nod",
                        "Accelerated Approval"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}